Clinical Trial Update: Survey to Describe Impact of Reflux Disease on Everyday Life in GERD Patients Before and After 4 Weeks Treatment.

View source ↗

Summary

A survey-based clinical trial completed by AstraZeneca to describe how gastroesophageal reflux disease affects daily life before and after four weeks of treatme…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Snippet

Sponsor: AstraZeneca | Conditions: Gastroesophageal Reflux Disease | Status: COMPLETED